Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia

HIV Clinical Trials
Leonardo CalzaPierluigi Viale

Abstract

Hyperlipidaemia is a risk factor for the progression of chronic kidney disease (CKD), which is a frequent comorbidity in patients with HIV-1 infection, but the renal effects of statins remain unclear. We performed an observational, prospective study of HIV-infected patients on suppressive antiretroviral therapy, with CKD and hyperlipidaemia, and starting a lipid-lowering treatment with rosuvastatin, atorvastatin or omega-3 fatty acids. CKD was defined as an estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73 m2 for >3 months. As a whole, 69 patients (53 men, 58 Caucasian, median age 56.2 years) were enrolled. Overall, 25 patients started rosuvastatin (10 mg daily, group A), 23 patients atorvastatin (20 mg daily, group B), and 21 started omega-3 fatty acids (3 g daily, group C). At baseline, median eGFR was 54.4 mL/min/1.73 m2, and the eGFR ranged between 50 and 60 mL/min/1.73 m2 in 87% of patients. After 12 months, the median eGFR decline was significantly lower in group A (-0.84 mL/min/1.73 m2) and in group B (-0.91 mL/min/1.73 m2) in comparison with the group C (-1.53 mL/min/1.73 m2; p < 0.001 for both comparisons). The median decrease in prevalence of proteinuria and high-sensitivity C-reactive protein was also sign...Continue Reading

References

Jun 10, 2006·Journal of the American Society of Nephrology : JASN·Sabrina SandhuMarcello Tonelli
Sep 26, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vasilios G AthyrosMoses Elisaf
Sep 7, 2007·Kidney International·A I ChoiA M O'Hare
Apr 9, 2009·AIDS·Chris T LongeneckerMichael G Shlipak
Sep 16, 2009·AIDS·Loveleen BansiUNKNOWN UK CHIC/ESRF study group
Oct 28, 2010·Expert Opinion on Pharmacotherapy·Anna GlubaMaciej Banach
Feb 9, 2012·AIDS·Rebecca ScherzerMichael G Shlipak
Apr 25, 2012·Current HIV/AIDS Reports·Peter W Hunt
Aug 8, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kevin P HighUNKNOWN OAR Working Group on HIV and Aging
Jul 6, 2012·The New England Journal of Medicine·Lesley A InkerUNKNOWN CKD-EPI Investigators
Dec 11, 2013·Clinical Nephrology·Robert G FassettJeff S Coombes
Mar 22, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lesley A InkerHarold I Feldman
Jul 13, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chris T LongeneckerGrace A McComsey
Nov 20, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G AbrahamUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to
Mar 1, 2015·Clinical Nephrology·Saraladevi NaickerJeffrey B Kopp
May 21, 2015·HIV Medicine·S K GuptaUNKNOWN AIDS Clinical Trials Group Study A5224s Team
Jan 19, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Zhenhong ZhangGengxin Zhang
Oct 4, 2016·International Journal of Nephrology and Renovascular Disease·Nina E Diana, Saraladevi Naicker
Jan 13, 2017·PloS One·Eun Yeong ChoJi Yong Jung
May 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrew T Y WongUNKNOWN Central Committee on Infectious Diseases and Emergency Response, Hospital Authority, Hong Kong Special Administrative Region
Jun 22, 2017·The Journal of Infectious Diseases·Jeffrey B Kopp

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.